Differences in glial reactivity could underlie sex differences in Alzheimer disease (AD), according to new research published in Molecular Psychiatry. The work emphasizes the importance of immune responses in AD and highlights the potential for tailored treatment approaches.

AD is not only more common among women than men, but its progression also tends to be faster in women. The reasons for these differences are unclear, but some evidence suggests that immune function could be important.